YELP insider tape update: Stoppelman Jeremy now at $219.4M cumulative sales, but timing is key
Stoppelman Jeremy's YELP insider record stands at $219.4M cumulative sales (latest filing 2026-02-02); focus on sequence, transaction-code mix, and ownership trend over time.
Stoppelman Jeremy's filing record in YELP now totals $219.4M. The latest update (2026-02-02) keeps this profile on active monitor lists.
Transaction Detail
| Date | Code | Shares | Price | Est. Value |
|---|---|---|---|---|
| 2026-02-05 | M | 6,200 | $20.47 | $127K |
| 2026-02-05 | S | 6,200 | $24.20 | $150K |
| 2026-02-05 | M | 6,200 | $20.47 | $127K |
| 2026-02-04 | M | 30,000 | $20.47 | $614K |
| 2026-02-04 | S | 600 | $25.37 | $15K |
| 2026-02-04 | S | 29,400 | $24.78 | $728K |
| 2026-02-04 | M | 30,000 | $20.47 | $614K |
| 2026-02-03 | M | 30,000 | $20.47 | $614K |
What Matters Most
Ownership slope and filing cadence typically outperform one-off notional values as predictors of future signal strength.
External Context Entry Point
Key Risk to Monitor
Further ownership step-down from 0 with similar or larger disposal cadence.
Related Research
Explore all researchFisher’s Q4 2025 filing was still packed with mega-cap tech, but the bigger tell was a giant Treasury and investment-grade corporate bond sleeve built through IEF and VCIT. The next filing will show whether that duration bet was tactical or structural.
Apr 17, 2026
Principal’s Q4 2025 filing looked slightly weaker on headline AUM, but the internal rotation was more revealing: Brookfield became a top-ten position, Netflix surged, and the fund cut back in parts of real estate. The next filing will show whether that shift keeps going.
Apr 17, 2026
Nuveen’s Q4 2025 filing stayed large-cap and AI-heavy at the top, but the more revealing addition was a sizable fixed-income sleeve through NXUS and NHYB. The next filing will show whether those credit and bond ETFs remain central or fade back out.
Apr 17, 2026
Victory Capital kept mega-cap tech on top in Q4 2025, but the sharper signal was in the secondary moves: large increases in Netflix, Constellation Energy, TSMC and new positions like IQVIA. The next filing will show whether that diversification continues.
Apr 17, 2026
Janus Henderson kept Nvidia and Microsoft on top in Q4 2025, but the more interesting signal was underneath: new exposure to Intuitive Surgical, Protagonist Therapeutics and other growth-healthcare names. The next filing will show whether that rotation keeps building.
Apr 17, 2026